MARK GILGER to Double-Blind Method
This is a "connection" page, showing publications MARK GILGER has written about Double-Blind Method.
Connection Strength
0.482
-
Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease. J Pediatr Gastroenterol Nutr. 2015 Jul; 60 Suppl 1:S16-23.
Score: 0.088
-
Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old. J Pediatr Gastroenterol Nutr. 2015 Jul; 60 Suppl 1:S31-6.
Score: 0.088
-
Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease. J Pediatr Gastroenterol Nutr. 2015 Jul; 60 Suppl 1:S16-23.
Score: 0.088
-
Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old. J Pediatr Gastroenterol Nutr. 2015 Jul; 60 Suppl 1:S31-6.
Score: 0.088
-
Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2008 May; 46(5):524-33.
Score: 0.054
-
Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study. J Pediatr Gastroenterol Nutr. 2015 Jul; 60 Suppl 1:S24-30.
Score: 0.022
-
Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study. J Pediatr Gastroenterol Nutr. 2015 Jul; 60 Suppl 1:S24-30.
Score: 0.022
-
Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old. J Pediatr Gastroenterol Nutr. 2010 Nov; 51(5):593-8.
Score: 0.016
-
Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study. BMC Pediatr. 2010 Jun 11; 10:41.
Score: 0.016